InMed Pharmaceuticals Inc. buy me8
Start price
20.03.23
/
0%
€1.30
Target price
20.03.24
-
Performance (%)
6.18%
End price
23.03.23
€1.38
Summary
This prediction ended on 23.03.23 with a price of €1.38. The BUY prediction by me8 finished with a performance of 6.18%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
InMed Pharmaceuticals Inc. | -10.224% | -10.224% | -70.588% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to me8 what are the pros and cons of InMed Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Cons
Little innovation
Comments by me8 for this prediction
In the thread Inmed Pharmaceuticals Inc. diskutieren
Buy InMed Pharmaceuticals Inc.
In the thread Trading InMed Pharmaceuticals Inc.
Buy beendet
Stopped prediction by me8 for InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€37.75
17.11.21
17.11.21
€50.00
17.11.22
17.11.22
4.64%
27.11.21
27.11.21
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation